http://www.fpnotebook.com/
OxcarbazepineAka: Trileptal
- Indications
- Simple Partial Seizures
- Complex Partial Seizures
- Generalized Tonic Clonic Seizures
- Trigeminal Neuralgia
- Mania
- Adverse Effects: Dose related
- Nausea or Vomiting
- Dizziness
- Ataxia
- Diplopia
- Sedation
- Lethargy
- Hyponatremia
- Tremor
- Adverse Effects: Other
- Hyponatremia
- Cardiac arrhythmia
- Dosing: Adults (includes elderly)
- Initial: 300 mg PO bid
- Increase by 600 mg/day weekly
- Target dose: 600 mg PO bid
|
|---|
| Definition (NCI) | A dibenzazepine carboxamide derivative with an anticonvulsant property. As a prodrug, oxcarbazepine is converted to its active metabolite, 10-monohydroxy. Although the mechanism of action has not been fully elucidated, electrophysiological studies indicate this agent blocks voltage-gated sodium channels, thereby stabilizing hyper-excited neural membranes, inhibiting repetitive neuronal firing, and decreasing the propagation of synaptic impulses. |
| Concepts | Organic Chemical (T109)
, Pharmacologic Substance (T121)
|
| English | oxcarbazepine, OXCARBAZEPINE PREPARATION |
| Spanish | oxcarbacepina, oxcarbazepina |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
|
|---|
| Concepts | Organic Chemical (T109)
, Pharmacologic Substance (T121)
|
| English | Novartis brand of oxcarbazepine, Trileptal |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Navigation Tree